Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers have now discovered that opioid delta-receptor agonists may ...
2d
News Medical on MSNOpioid δ-receptor agonists show promise for treating IBS-like symptomsResearch reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...
4d
News Medical on MSNNew drug class may help alleviate IBS symptoms by targeting the central nervous systemIrritable bowel syndrome (IBS) is a common digestive disorder that affects the intestine, causing symptoms such as abdominal pain, bloating, gas, and changes in bowel habits, including diarrhea, ...
Functional abdominal pain (FAP) and irritable bowel syndrome (IBS) are among the most commonly diagnosed medical problems in pediatrics. Symptom-based Rome III criteria for FAP and IBS have been ...
metabolic or neoplastic process that explains the subject's symptoms Diagnosis of functional abdominal pain and irritable bowel syndrome in children is based on signs and symptoms, and should take ...
Using an innovative and recently validated animal model of IBS, the researchers showed that opioid delta-receptor agonists can ameliorate stress-induced IBS symptoms by acting on the insular cortex of ...
Poor diet quality and food diversity was associated with higher risk for severe symptoms in patients with IBS.
In addition, IBS pain may feel like abdominal cramping or aching. Irritable bowel syndrome self-care measures—such as dietary changes, stress management, and exercise—can provide short- and long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results